Suchergebnisse - (Subject:"ritonavir")

PubPharm (6.437)

61

Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents : an approach for drug use

enthalten in: European journal of hospital pharmacy : science and practice | 2024

von Visscher, R. | Yalçın, N. | Bayraktar, I. | +1

62

A pilot study on Paxlovid therapy for hemodialysis patients with severe acute respiratory syndrome coronavirus 2 infections

enthalten in: Frontiers of medicine | 2024

von Hao, X. | Bao, Z. | Dai, R. | +13

63

Paxlovid Is Effective but Underused-Here's What the Latest Research Says About Rebound and More

enthalten in: JAMA | 2024

von Rubin, R.

64

Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron : An updated meta-analysis

enthalten in: Journal of medical virology | 2024

von Ombelet, S. | Castanares-Zapatero, D. | Desimpel, F. | +3

65

Physiologically based Pharmacokinetic Model Validated to Enable Predictions Of Multiple Drugs in a Long-acting Drug-combination Nano-Particles (DcNP) : Confirmation with 3 HIV Drugs, Lopinavir, Ritonavir, and Tenofovir in DcNP Products

enthalten in: Journal of pharmaceutical sciences | 2024

von Perazzolo, S. | Shen, D. | Scott, A. | +1

66

COVID-19 : On the threshold of the fifth year. The situation in Spain

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2024

von Rodríguez-Artalejo, F. | Ruiz-Galiana, J. | Cantón, R. | +13

67

Antiviral effectiveness and survival correlation of azvudine and nirmatrelvir/ritonavir in elderly severe patients with COVID-19 : a retrospective real-world study

enthalten in: EClinicalMedicine | 2024

von Wang, S. | Sun, J. | Zhang, X. | +44

68

Determining and Comparing the Real-World Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19

enthalten in: Journal of Korean medical science | 2024

von Jang, Y. | Oh, Y. | Kim, J.

69

Nirmatrelvir Resistance-de Novo E166V/L50V Mutations in an Immunocompromised Patient Treated With Prolonged Nirmatrelvir/Ritonavir Monotherapy Leading to Clinical and Virological Treatment Failure-a Case Report

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Zuckerman, N. | Bucris, E. | Keidar-Friedman, D. | +2

70

Characteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Gentry, C. | Nguyen, P. | Thind, S. | +2